Jenburkt Pharmaceuticals Limited
BSE: JENBURPH.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Ashish Uttam Bhuta
- Employees
- 752
- Headquarters
- Mumbai, India
- IPO year
- 2000
- Market cap
- ₹5.1B
- Website
- http://www.jenburkt.com
Loading JENBURPH…
Loading profile data…Frequently asked questions about JENBURPH
What does Jenburkt Pharmaceuticals Limited (JENBURPH.BO) do?
Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products. The firm offers anthelmintic, anti-osteoporotic, anti-arthritic, anti-ulcerants, antibiotics, aphrodisiac, anti-cough, and cold and allergy dermatological products. It operates through the following segments: Local and E...
Where does JENBURPH.BO trade?
Jenburkt Pharmaceuticals Limited (JENBURPH.BO) trades on the Bombay Stock Exchange.
What sector is JENBURPH.BO in?
Jenburkt Pharmaceuticals Limited (JENBURPH.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Jenburkt Pharmaceuticals Limited?
Ashish Uttam Bhuta is the chief executive officer of Jenburkt Pharmaceuticals Limited (JENBURPH.BO).
Where is Jenburkt Pharmaceuticals Limited headquartered?
Jenburkt Pharmaceuticals Limited is headquartered in India.
Does JENBURPH.BO pay a dividend?
Yes — Jenburkt Pharmaceuticals Limited (JENBURPH.BO) paid a trailing twelve-month dividend of INR 18.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did JENBURPH.BO go public?
Jenburkt Pharmaceuticals Limited (JENBURPH.BO) completed its initial public offering in 2000.